Predictors of failure to complete treatment for latent tuberculosis infection

被引:48
作者
Parsyan, Armen E.
Saukkonen, Jussi
Barry, M. Anita
Sharnprapai, Sharon
Horsburgh, C. Robert, Jr.
机构
[1] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[3] Massachusetts Dept Publ Hlth, Div TB Prevent & Control, Boston, MA USA
[4] Boston Publ Hlth Commiss, Boston, MA USA
关键词
latent tuberculosis; treatment; completion; LTBI;
D O I
10.1016/j.jinf.2006.04.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Low rates of completion of treatment for latent tuberculosis infection (LTBI) limit its usefulness as a strategy for elimination of tuberculosis (TB) in the United States. This retrospective cohort study assessed predictors of completion of LTBI treatment among patients seen at an urban United States TB clinic in 1998. Methods: A retrospective cohort study of acceptance and completion of LTBI treatment among patients first seen in a TB clinic in 1998 was performed. Results: Of 2621 persons with a positive tuberculosis skin test (TST), 1723 were offered treatment and 1572 (91.2%) accepted. Of the 1572 who accepted, treatment was completed by 607 (38.6%). Of those persons who failed to complete treatment, 517/965 (54%) dropped out before the end of the first month of the course. Among 1375 persons under 35 years of age who initiated LTBI treatment, failure to complete was associated with birth in Haiti (OR = 2.17, CI95% 1.49-3.17) or the Dominican Republic (OR = 1.93, Cl-95% 1.08-3.43). Conclusion: These results suggest that country-specific cultural and behavioral factors may contribute to failure to complete LTBI treatment, and that interventions to increase completion should focus on the first month after initiation. (C) 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 22 条
[1]   Adherence to tuberculosis preventive therapy among Latino immigrants [J].
Ailinger, RL ;
Dear, MR .
PUBLIC HEALTH NURSING, 1998, 15 (01) :19-24
[2]  
[Anonymous], AM J RESP CRIT CARE
[3]   A tuberculin screening and isoniazid preventive therapy program in an inner-city population [J].
Bock, NM ;
Metzger, BS ;
Tapia, JR ;
Blumberg, HM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :295-300
[4]   Completion of screening for latent tuberculosis infection among immigrants [J].
Carvalho, ACC ;
Saleri, N ;
El-Hamad, I ;
Tedoldi, S ;
Capone, S ;
Pezzoli, MC ;
Zaccaria, M ;
Pizzocolo, A ;
Scarcella, C ;
Matteelli, A .
EPIDEMIOLOGY AND INFECTION, 2005, 133 (01) :179-185
[5]  
Coly A, 2004, INT J TUBERC LUNG D, V8, P703
[6]  
Driver CR, 2003, INT J TUBERC LUNG D, V7, pS432
[7]  
FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28
[8]   Treatment of latent tuberculosis infection in patients aged ≥35 years [J].
Gilroy, SA ;
Rogers, MAM ;
Blair, DC .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (03) :826-829
[9]  
Goldberg SV, 2004, INT J TUBERC LUNG D, V8, P76
[10]   Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial [J].
Jasmer, RM ;
Saukkonen, JJ ;
Blumberg, HM ;
Daley, CL ;
Bernardo, J ;
Vittinghoff, E ;
King, MD ;
Kawamura, LM ;
Hopewell, PC .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (08) :640-647